Tag: Biosimilar
FDA Simplifies Biosimilar Approvals; Patents And Payment Issues Remain
Biosimilars are a type of biologic medication that is designed to be highly similar to an already approved…
PBM And Drug Maker Rebate Game Limits Biosimilar Competition
Optimizing Biosimilar Competition in the U.S. Market Beginning in 2023, five years after their European counterparts, patients in…